Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

eql pharma ab - methenaminhippurat - tabletter - 1 g

Danmark - dansk - SEGES Landbrug & Fødevarer

bayer a/s - fenhexamid - vanddispergerbart granulat - 500 g/kg fenhexamid

Den Europæiske Union - dansk - EMA (European Medicines Agency)

oncopeptides ab - melphalan flufenamide hydrochloride - multipelt myelom - antineoplastiske midler - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - benserazidhydrochlorid, levodopa - kapsler, hårde - 100+25 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - benserazidhydrochlorid, levodopa - kapsler, hårde - 200+50 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - benserazidhydrochlorid, levodopa - kapsler, hårde - 50+12,5 mg

Danmark - dansk - SEGES Landbrug & Fødevarer

certis europe bv - cyflufenamid - olie i vand emulsion - 51,3 g/l cyflufenamid